Enhancement of oral absorption in selective 5-HT1D receptor agonists:: Fluorinated 3-[3-(piperidin-1-yl)propyl]indoles

被引：25
|
作者：
Castro, JL
Collins, I
Russell, MGN
Watt, AP
Sohal, B
Rathbone, D
Beer, MS
Stanton, JA
机构：
[1] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Chem, Harlow CM20 2QR, Essex, England
[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Dept Biochem, Harlow CM20 2QR, Essex, England
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1998年 / 41卷 / 15期
关键词：
D O I：
10.1021/jm980204e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2667 / 2670
页数：4
相关论文
共 50 条
  • [1] 3-[3-(Piperidin-1-yl)propyl] indoles as highly selective h5-HT1D receptor agonists
    Russell, MGN
    Matassa, VG
    Pengilley, RR
    van Niel, MB
    Sohal, B
    Watt, AP
    Hitzel, L
    Beer, MS
    Stanton, JA
    Broughton, HB
    Castro, JL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) : 4981 - 5001
  • [2] Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles
    van Niel, MB
    Collins, I
    Beer, MS
    Broughton, HB
    Cheng, SKF
    Goodacre, SC
    Heald, A
    Locker, KL
    MacLeod, AM
    Morrison, D
    Moyes, CR
    O'Connor, D
    Pike, A
    Rowley, M
    Russell, MGN
    Moyes, CR
    O'Connor, D
    Pike, A
    Rowley, M
    Russell, MGN
    Sohal, B
    Stanton, JA
    Thomas, S
    Verrier, H
    Watt, AP
    Castro, JL
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (12) : 2087 - 2104
  • [3] 3-[2-(pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: Agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype
    Castro, JL
    Street, LJ
    Guiblin, AR
    Jelley, RA
    Russell, MGN
    Sternfeld, F
    Beer, MS
    Stanton, JA
    Matassa, VG
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (22) : 3497 - 3500
  • [4] 3-[2-(pyrrolidin-1-yl)ethyl]indoles and analogues: Agonists for the 5-HT1D receptor with high selectivity over the 5-HT1D subtype.
    Street, LJ
    Castro, JL
    Guiblin, AR
    Jelley, R
    Matassa, VG
    Russell, MGN
    Sternfeld, F
    Beer, M
    Stanton, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 47 - MEDI
  • [5] 3-(Piperazinylpropyl)indoles:: h5-HT1D receptor agonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (07) : 333 - 333
  • [6] 3-[3-(piperazin-1-yl)propyl]indoles:: Agonists for the h5-HT10 receptor with high selectivity over the h5-HT10 receptor
    Reeve, AJ
    Hobbs, SC
    Jelley, RA
    Sternfeld, F
    Street, LJ
    Beer, MS
    Heald, A
    Stanton, JA
    MacLeod, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1228 - U1228
  • [7] A 1:1 adduct of 3-(piperidin-1-yl)propionic acid with triphenyltin chloride
    Yan, YK
    Khoo, LE
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : M781 - M783
  • [8] 3-(Piperidin-1-yl)-6-(1H-pyrazol-1-yl)pyridazine
    Ather, Abdul Qayyum
    Sahin, Onur
    Khan, Islam Ullah
    Khan, Misbahul Ain
    Buyukgungor, Orhan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1295 - U429
  • [9] 3-(piperazinylpropyl)indoles:: Selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents
    Chambers, MS
    Street, LJ
    Goodacre, S
    Hobbs, SC
    Hunt, P
    Jelley, RA
    Matassa, VG
    Reeve, AJ
    Sternfeld, F
    Beer, MS
    Stanton, JA
    Rathbone, D
    Watt, AP
    MacLeod, AM
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (04) : 691 - 705
  • [10] 3-[(2-Hydroxy-1-naphthyl)(piperidin-1-yl)methyl]benzonitrile
    Qu, Zhi-Rong
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O3429 - U2740
12345